Showing results (881-890 of 7,009) with videos related to

Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|April 16, 2004
Outcome of patients with pulmonary carcinoid tumors receiving chemotherapy or chemoradiotherapyLori J Wirth, Mark R Carter, Pasi A Jänne, et al.
Lung Cancer (Amsterdam, Netherlands)|January 11, 2005
Duration of smoking abstinence as a predictor for non-small-cell lung cancer survival in womenJ O Ebbert, B A Williams, Z Sun, et al.
Lung Cancer (Amsterdam, Netherlands)|January 11, 2005
Ribonucleotide reductase M1 gene promoter activity, polymorphisms, population frequencies, and clinical relevanceGerold Bepler, Zhong Zheng, Ashish Gautam, et al.
Lung Cancer (Amsterdam, Netherlands)|June 16, 2004
A treatment planning study evaluating a 'simultaneous integrated boost' technique for accelerated radiotherapy of stage III non-small cell lung cancerMaarten L P Dirkx, John R van Sörnsen De Koste, Suresh Senan
Lung Cancer (Amsterdam, Netherlands)|October 12, 2004
Susceptibility of mesothelioma cell lines to adeno-associated virus 2 vector-based suicide gene therapySimone Berlinghoff, Marlon R Veldwijk, Stephanie Laufs, et al.
Lung Cancer (Amsterdam, Netherlands)|October 12, 2004
Validating the prognostic value of marker genes derived from a non-small cell lung cancer microarray studyFiona H Blackhall, Dennis A Wigle, Igor Jurisica, et al.
Lung Cancer (Amsterdam, Netherlands)|October 12, 2004
The biology of non-small-cell lung cancer: identifying new targets for rational therapyR Rosell, E Felip, R Garcia-Campelo, et al.
Lung Cancer (Amsterdam, Netherlands)|October 12, 2004
The beneficial effects of specialist thoracic surgery on the resection rate for non-small-cell lung cancerAntonio E Martin-Ucar, David A Waller, Jane L Atkins, et al.
Lung Cancer (Amsterdam, Netherlands)|October 12, 2004
Retrospective analysis of the predictive factors associated with the response and survival benefit of gefitinib in patients with advanced non-small-cell lung cancerHiroyasu Kaneda, Kenji Tamura, Takayasu Kurata, et al.
Lung Cancer (Amsterdam, Netherlands)|September 15, 2004
In vivo identification of sentinel lymph nodes for clinical stage I non-small cell lung cancer for abbreviation of mediastinal lymph node dissectionHiroaki Nomori, Kenichi Watanabe, Takashi Ohtsuka, et al.
Pageof 701